In the BioHarmony Drug Report Database

"Preview" Icon

Imiglucerase

Cerezyme (imiglucerase) is an enzyme pharmaceutical. Imiglucerase was first approved as Cerezyme on 1994-05-23. It is used to treat gaucher disease, liver diseases, and splenic diseases in the USA. It has been approved in Europe to treat gaucher disease.

 

Trade Name

 

Cerezyme
 

Common Name

 

imiglucerase
 

ChEMBL ID

 

CHEMBL1201632
 

Indication

 

gaucher disease, liver diseases, splenic diseases
 

Drug Class

 

Enzymes

Image (chem structure or protein)

Imiglucerase structure rendering